U. Tacke, MD, PhD, H. Uosukainen, MSci (Pharm), M. Kananen, BSci (Pharm), K. Kontra, Pharm Lic, and H. Pentikäinen, MD, “A pilot study about the feasibility and cost-effectiveness of electronic compliance monitoring in substitution treatment with buprenorphine—naloxone combination”, J of Opioid Management, vol. 5, no. 6, pp. 321–329, Jan. 2018.